Polymed Biopharmaceuticals, Inc
- Biotech or pharma, therapeutic R&D
Polymed Biopharmaceuticals is seeking strategic partners to advance our pipeline of optimized PROTACs and DACs as well as our clinic-ready asset having an FDA-cleared IND targeting FLT3 and IRAK4 for patients with AML and MDS.
Polymed is a part of the J&J JLABS Innovation Network with global operations based in Hangzhou, Shanghai, and Cambridge, MA.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}